Cardiology

Knowing that cardiology is the second most important specialty at SCRC, many efforts are put into safety, credibility, cost control, adaptability and rapidity of clinical trials in this field.

Our knowledge goes from the conduction of mega clinical trials in different sites and nations through the entire drug development process to the acceleration of regulatory submissions.

Cardiovascular drug development is possible at SCRC thanks to the use of the right resources at the right time. The professional team is there to control this process and that’s why it is trained regularly to several general and/or specialized cardiovascular issues.